Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

ClinicalTrials.gov ID: NCT01190449

Public ClinicalTrials.gov record NCT01190449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 3, 2026, 8:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Ofatumumab (CALGB IND #) in Previously Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Monoclonal antibodies, such as ofatumumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. PURPOSE: This randomized phase II trial is studying ofatumumab to see how well it works in treating patients with previously untreated stage II, stage III, or stage IV follicular non-Hodgkin lymphoma.

Study identification

NCT ID
NCT01190449
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
51 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2011 (Actual)
Primary completion
Mar 2015 (Actual)
Completion
Oct 15, 2020 (Actual)
Last update posted
Aug 18, 2021

2011 – 2020

United States locations

U.S. sites
48
U.S. states
13
U.S. cities
37
Facility City State ZIP Site status
Tunnell Cancer Center at Beebe Medical Center Lewes Delaware 19958 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Cleveland Clinic Florida - Weston Weston Florida 33331 —
Illinois CancerCare - Bloomington Bloomington Illinois 61701 —
Illinois CancerCare - Canton Canton Illinois 61520 —
Eureka Community Hospital Eureka Illinois 61530 —
Illinois CancerCare - Eureka Eureka Illinois 61530 —
Galesburg Clinic, PC Galesburg Illinois 61401 —
Illinois CancerCare - Macomb Macomb Illinois 61455 —
BroMenn Regional Medical Center Normal Illinois 61761 —
Community Cancer Center Normal Illinois 61761 —
Illinois CancerCare - Community Cancer Center Normal Illinois 61761 —
Community Hospital of Ottawa Ottawa Illinois 61350 —
Oncology Hematology Associates of Central Illinois, PC - Ottawa Ottawa Illinois 61350 —
Cancer Treatment Center at Pekin Hospital Pekin Illinois 61554 —
Illinois CancerCare - Pekin Pekin Illinois 61603 —
Proctor Hospital Peoria Illinois 61614 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61615 —
Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria Illinois 61615 —
Methodist Medical Center of Illinois Peoria Illinois 61636 —
Illinois CancerCare - Peru Peru Illinois 61354 —
Illinois Valley Community Hospital Peru Illinois 61354 —
Illinois CancerCare - Spring Valley Spring Valley Illinois 61362 —
Iowa Blood and Cancer Care Cedar Rapids Iowa 52402 —
Union Hospital of Cecil County Elkton Maryland 21921 —
Battle Creek Health System Cancer Care Center Battle Creek Michigan 49017 —
Mecosta County Medical Center Big Rapids Michigan 49307 —
Butterworth Hospital at Spectrum Health Grand Rapids Michigan 49503 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
Lacks Cancer Center at Saint Mary's Health Care Grand Rapids Michigan 49503 —
Mercy General Health Partners Muskegon Michigan 49444 —
Spectrum Health Reed City Hospital Reed City Michigan 49677 —
Munson Medical Center Traverse City Michigan 49684 —
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110 —
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord New Hampshire 03301 —
New Hampshire Oncology - Hematology, PA - Hooksett Hooksett New Hampshire 03106 —
Lakes Region General Hospital Laconia New Hampshire 03246 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
Monter Cancer Center of the North Shore-LIJ Health System Lake Success New York 11042 —
Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset New York 11030 —
Mount Kisco Medical Group, PC Mount Kisco New York 10549-3417 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
New York Weill Cornell Cancer Center at Cornell University New York New York 10021 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
Kinston Medical Specialists Kinston North Carolina 28501 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus Ohio 43210-1240 —
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01190449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2021 · Synced Oct 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01190449 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →